Lice Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice
Condition:   Head Lice Interventions:   Drug: Ivermectin 0.5% Topical Application Lotion;   Drug: Ivermectin 0.5% Topical Application Lotion [SKLICE];   Drug: Placebo 0% Lotion Sponsor:   bioRASI, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2017 Category: Research Source Type: clinical trials